About this Event
1824 6th Avenue South, Birmingham, AL 35233
O'Neal Research Seminar hosted by the Experimental Therapeutics Program.
“A Phase 1B/II Dose Escalation and Dose Expansion Study of Valemetostat Tosylate (DS-DS-3201b) with Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma”
Mehmet Akce, M.D.
UAB Division of Hematology & Oncology
“Acarbose in Combination with Standard of Care Therapy in RCC”
Arnab Basu, M.D.
UAB Division of Hematology & Oncology
“Siltuximab for the Treatment of CAR T-cell Associated CRS and ICANS”
Mayur Narkhede, M.D.
UAB Division of Hematology & Oncology
“Minimal Residual Disease Response-Adapted Deferral of Transplant in Dysproteinemia- MILESTONE Trial”
Susan Bal, M.D.
UAB Division of Hematology & Oncology
Event Details
As a public institution of higher education, UAB adheres to principles of Free Speech, Civil Discourse and Institutional Neutrality. Freedom of Expression and Use of UAB Facilities Policy allows members of the UAB community to hold events on campus; views expressed do not represent the university, which adheres to institutional neutrality. Events held at UAB are required to comply with all applicable state and federal laws, and participation is not limited based on impermissible criteria (e.g., age, gender, race, national origin, sexual orientation).
See Who Is Interested
1 person is interested in this event